REPORT ID 20444

United States Antiemetic Drugs Market Report 2016

Publish Date
14-Oct
Pages
118
Format
Electronic (PDF)

Notes:
Sales, means the sales volume of Antiemetic Drugs
Revenue, means the sales value of Antiemetic Drugs

This report studies sales (consumption) of Antiemetic Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
    GlaxoSmithKline
    Pfizer Inc.
    Johnson and Johnson
    Astellas Pharma
    Merck
    Sanofi-Aventis
    Baxter International
    Abbott Labs
    Cipla Ltd.
    Novartis AG

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
    Type I
    Type II
    Type III
Split by applications, this report focuses on sales, market share and growth rate of  Antiemetic Drugs in each application, can be divided into
    Chemotherapy
    Pregnancy
    Motion Sickness
    Food Poisoning
    Gastroenteritis
    Diziness
    General Anesthetics
    Opiod Analgesics
    Emotional Stress
    Others

 
			   
Table of Contents

United States Antiemetic Drugs Market Report 2016
1 Antiemetic Drugs Overview
    1.1 Product Overview and Scope of Antiemetic Drugs
    1.2 Classification of Antiemetic Drugs
        1.2.1 Type I
        1.2.2 Type II
        1.2.3 Type III
    1.3 Application of Antiemetic Drugs
        1.3.1 Chemotherapy
        1.3.2 Pregnancy
        1.3.3 Motion Sickness
        1.3.4 Food Poisoning
        1.3.5 Gastroenteritis
        1.3.6 Diziness
        1.3.7 General Anesthetics
        1.3.8 Opiod Analgesics
        1.3.9 Emotional Stress
        1.3.10 Others
    1.4 United States Market Size Sales (Value) and Revenue (Volume) of Antiemetic Drugs (2011-2021)
        1.4.1 United States Antiemetic Drugs Sales and Growth Rate (2011-2021)
        1.4.2 United States Antiemetic Drugs Revenue and Growth Rate (2011-2021)

2 United States Antiemetic Drugs Competition by Manufacturers
    2.1 United States Antiemetic Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
    2.2 United States Antiemetic Drugs Revenue and Share by Manufactures (2015 and 2016)
    2.3 United States Antiemetic Drugs Average Price by Manufactures (2015 and 2016)
    2.4 Antiemetic Drugs Market Competitive Situation and Trends
        2.4.1 Antiemetic Drugs Market Concentration Rate
        2.4.2 Antiemetic Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion

3 United States Antiemetic Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)
    3.1 United States Antiemetic Drugs Sales and Market Share by Type (2011-2016)
    3.2 United States Antiemetic Drugs Revenue and Market Share by Type (2011-2016)
    3.3 United States Antiemetic Drugs Price by Type (2011-2016)
    3.4 United States Antiemetic Drugs Sales Growth Rate by Type (2011-2016)

4 United States Antiemetic Drugs Sales (Volume) by Application (2011-2016)
    4.1 United States Antiemetic Drugs Sales and Market Share by Application (2011-2016)
    4.2 United States Antiemetic Drugs Sales Growth Rate by Application (2011-2016)
    4.3 Market Drivers and Opportunities

5 United States Antiemetic Drugs Manufacturers Profiles/Analysis
    5.1 GlaxoSmithKline
        5.1.1 Company Basic Information, Manufacturing Base and Competitors
        5.1.2 Antiemetic Drugs Product Type, Application and Specification
            5.1.2.1 Type I
            5.1.2.2 Type II
        5.1.3 GlaxoSmithKline Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        5.1.4 Main Business/Business Overview
    5.2 Pfizer Inc.
        5.2.2 Antiemetic Drugs Product Type, Application and Specification
            5.2.2.1 Type I
            5.2.2.2 Type II
        5.2.3 Pfizer Inc. Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        5.2.4 Main Business/Business Overview
    5.3 Johnson and Johnson
        5.3.2 Antiemetic Drugs Product Type, Application and Specification
            5.3.2.1 Type I
            5.3.2.2 Type II
        5.3.3 Johnson and Johnson Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        5.3.4 Main Business/Business Overview
    5.4 Astellas Pharma
        5.4.2 Antiemetic Drugs Product Type, Application and Specification
            5.4.2.1 Type I
            5.4.2.2 Type II
        5.4.3 Astellas Pharma Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        5.4.4 Main Business/Business Overview
    5.5 Merck
        5.5.2 Antiemetic Drugs Product Type, Application and Specification
            5.5.2.1 Type I
            5.5.2.2 Type II
        5.5.3 Merck Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        5.5.4 Main Business/Business Overview
    5.6 Sanofi-Aventis
        5.6.2 Antiemetic Drugs Product Type, Application and Specification
            5.6.2.1 Type I
            5.6.2.2 Type II
        5.6.3 Sanofi-Aventis Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        5.6.4 Main Business/Business Overview
    5.7 Baxter International
        5.7.2 Antiemetic Drugs Product Type, Application and Specification
            5.7.2.1 Type I
            5.7.2.2 Type II
        5.7.3 Baxter International Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        5.7.4 Main Business/Business Overview
    5.8 Abbott Labs
        5.8.2 Antiemetic Drugs Product Type, Application and Specification
            5.8.2.1 Type I
            5.8.2.2 Type II
        5.8.3 Abbott Labs Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        5.8.4 Main Business/Business Overview
    5.9 Cipla Ltd.
        5.9.2 Antiemetic Drugs Product Type, Application and Specification
            5.9.2.1 Type I
            5.9.2.2 Type II
        5.9.3 Cipla Ltd. Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        5.9.4 Main Business/Business Overview
    5.10 Novartis AG
        5.10.2 Antiemetic Drugs Product Type, Application and Specification
            5.10.2.1 Type I
            5.10.2.2 Type II
        5.10.3 Novartis AG Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        5.10.4 Main Business/Business Overview

6 Antiemetic Drugs Manufacturing Cost Analysis
    6.1 Antiemetic Drugs Key Raw Materials Analysis
        6.1.1 Key Raw Materials
        6.1.2 Price Trend of Key Raw Materials
        6.1.3 Key Suppliers of Raw Materials
        6.1.4 Market Concentration Rate of Raw Materials
    6.2 Proportion of Manufacturing Cost Structure
        6.2.1 Raw Materials
        6.2.2 Labor Cost
        6.2.3 Manufacturing Expenses
    6.3 Manufacturing Process Analysis of Antiemetic Drugs

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
    7.1 Antiemetic Drugs Industrial Chain Analysis
    7.2 Upstream Raw Materials Sourcing
    7.3 Raw Materials Sources of Antiemetic Drugs Major Manufacturers in 2015
    7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
    8.1 Marketing Channel
        8.1.1 Direct Marketing
        8.1.2 Indirect Marketing
        8.1.3 Marketing Channel Development Trend
    8.2 Market Positioning
        8.2.1 Pricing Strategy
        8.2.2 Brand Strategy
        8.2.3 Target Client
    8.3 Distributors/Traders List

9 Market Effect Factors Analysis
    9.1 Technology Progress/Risk
        9.1.1 Substitutes Threat
        9.1.2 Technology Progress in Related Industry
    9.2 Consumer Needs/Customer Preference Change
    9.3 Economic/Political Environmental Change

10 United States Antiemetic Drugs Market Forecast (2016-2021)
    10.1 United States Antiemetic Drugs Sales, Revenue Forecast (2016-2021)
    10.2 United States Antiemetic Drugs Sales Forecast by Type (2016-2021)
    10.3 United States Antiemetic Drugs Sales Forecast by Application (2016-2021)
    10.4 Antiemetic Drugs Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
    Author List
    Disclosure Section
    Research Methodology
    Data Source
    Disclaimer